NCCN 2013 Congress Series™: Utilizing Guidelines to Customize Patient Care in NSCLC - Biomarkers and Testing in Lung Cancer
This live webinar series is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with non-small cell lung cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for non-small cell lung cancer.
Target Audience
Learning Objectives
- Discuss the considerations and challenges of obtaining appropriate tissue samples
- Describe the molecular testing considerations for patients with ALK rearrangements and EGFR mutations
- Describe the role of the pathologist on the oncology healthcare team
Christine M. Lovly, MD, PhD
Vanderbilt-Ingram Cancer Center
This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information
Available Credit
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician
Price
Required Hardware/software
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- Adobe Reader or other PDF reader software for certificate viewing/printing